These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The influence of metal-complexing macrocycle size on intramolecular movement in rotaxanes. Woźny M; Tomczyk KM; Więckowska A; Sutuła S; Trzybiński D; Woźniak K; Korybut-Daszkiewicz B Dalton Trans; 2019 May; 48(19):6546-6557. PubMed ID: 31011729 [TBL] [Abstract][Full Text] [Related]
47. Towards controlling the threading direction of a calix[6]arene wheel by using nonsymmetric axles. Arduini A; Bussolati R; Credi A; Faimani G; Garaudée S; Pochini A; Secchi A; Semeraro M; Silvi S; Venturi M Chemistry; 2009; 15(13):3230-42. PubMed ID: 19206116 [TBL] [Abstract][Full Text] [Related]
48. Characterization of the cytotoxic activity of [2]rotaxane (TRO-A0001), a novel supramolecular compound, in cancer cells. Fujita Y; Kimura M; Sato H; Takata T; Ono N; Nishio K Arch Pharm Res; 2016 Jun; 39(6):825-32. PubMed ID: 27052614 [TBL] [Abstract][Full Text] [Related]
49. Switchable synchronisation of pirouetting motions in a redox-active [3]rotaxane. Schröder HV; Mekic A; Hupatz H; Sobottka S; Witte F; Urner LH; Gaedke M; Pagel K; Sarkar B; Paulus B; Schalley CA Nanoscale; 2018 Dec; 10(45):21425-21433. PubMed ID: 30427015 [TBL] [Abstract][Full Text] [Related]
51. Channels and cavities lined with interlocked components: metal-based polyrotaxanes that utilize pyridinium axles and crown ether wheels as ligands. Davidson GJ; Loeb SJ Angew Chem Int Ed Engl; 2003 Jan; 42(1):74-7. PubMed ID: 19757595 [No Abstract] [Full Text] [Related]
52. Calix[4]arene-based rotaxane host systems for anion recognition. McConnell AJ; Serpell CJ; Thompson AL; Allan DR; Beer PD Chemistry; 2010 Jan; 16(4):1256-64. PubMed ID: 19950342 [TBL] [Abstract][Full Text] [Related]
53. Cyclodextrin-based size-complementary [3]rotaxanes: selective synthesis and specific dissociation. Akae Y; Koyama Y; Kuwata S; Takata T Chemistry; 2014 Dec; 20(51):17132-6. PubMed ID: 25351559 [TBL] [Abstract][Full Text] [Related]
54. Host-rotaxanes with oligomeric axles are intracellular transport agents. Zhu J; McFarland-Mancini M; Drew AF; Smithrud DB Bioorg Med Chem Lett; 2009 Jan; 19(2):520-3. PubMed ID: 19081721 [TBL] [Abstract][Full Text] [Related]
55. Molecular dynamics study of 2rotaxanes: influence of solvation and cation on co-conformation. Fradera X; Márquez M; Smith BD; Orozco M; Luque FJ J Org Chem; 2003 Jun; 68(12):4663-73. PubMed ID: 12790569 [TBL] [Abstract][Full Text] [Related]
56. Controlling the rate of shuttling motions in [2]rotaxanes by electrostatic interactions: a cation as solvent-tunable brake. Ghosh P; Federwisch G; Kogej M; Schalley CA; Haase D; Saak W; Lützen A; Gschwind RM Org Biomol Chem; 2005 Aug; 3(15):2691-700. PubMed ID: 16032347 [TBL] [Abstract][Full Text] [Related]
57. Templated conversion of a crown ether-containing macrobicycle into [2]rotaxanes. Mahoney JM; Shukla R; Marshall RA; Beatty AM; Zajicek J; Smith BD J Org Chem; 2002 Mar; 67(5):1436-40. PubMed ID: 11871870 [TBL] [Abstract][Full Text] [Related]
58. Pt-rotaxanes as cytotoxic agents. Wang X; Smithrud DB Bioorg Med Chem Lett; 2011 Nov; 21(22):6880-3. PubMed ID: 21978681 [TBL] [Abstract][Full Text] [Related]
60. Face-selective [2]- and [3]rotaxanes: kinetic control of the threading direction of cyclodextrins. Oshikiri T; Takashima Y; Yamaguchi H; Harada A Chemistry; 2007; 13(25):7091-8. PubMed ID: 17563911 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]